These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11877595)

  • 21. Apo E gene polymorphism on development of diabetic nephropathy.
    Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
    Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile.
    Leiva E; Mujica V; Orrego R; Prieto M; Arredondo M
    Diabetes Res Clin Pract; 2005 Jun; 68(3):244-9. PubMed ID: 15936467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town.
    Pasquariello A; Pasquariello G; Innocenti M; Minnei F; Funel N; Lorusso P; Barsotti G
    J Nephrol; 2011; 24(3):381-5. PubMed ID: 21534236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
    Oikawa S; Suzuki N; Sakuma E; Saito T; Namai K; Kotake H; Fujii Y; Toyota T
    Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
    J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
    Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional structure of the LDL receptor-binding domain of the human apolipoprotein E2 (Arg136-->Cys) variant.
    Feussner G; Albanese M; Valencia A
    Atherosclerosis; 1996 Oct; 126(2):177-84. PubMed ID: 8902143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.
    Chen S; Liu ZH; Zheng JM; Zhang X; Li LS
    J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I.
    Takasaki S; Matsunaga A; Joh K; Saito T
    CEN Case Rep; 2018 May; 7(1):127-131. PubMed ID: 29356944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature.
    Saito T; Sato H; Oikawa S; Kudo K; Kurihara I; Nakayama K; Abe K; Yoshinaga K; Sakaguchi H
    Am J Nephrol; 1993; 13(1):64-8. PubMed ID: 8322843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.
    Karube M; Nakabayashi K; Fujioka Y; Yoshihara K; Yamada A; Matsunaga A; Saito T
    Clin Exp Nephrol; 2007 Jun; 11(2):174-179. PubMed ID: 17593519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of diagnosing lipoprotein glomerulopathy in Russia].
    Sipovskii VG; Klemina IK; Zverkov RV; Dobronravov VA; Smirnov AV
    Arkh Patol; 2016; 78(6):52-57. PubMed ID: 28139603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rare cause of nephrotic syndrome: lipoprotein glomerulopathy.
    Cheung CY; Chan AO; Chan YH; Lee KC; Chan GP; Lau GT; Shek CC; Chau KF; Li CS
    Hong Kong Med J; 2009 Feb; 15(1):57-60. PubMed ID: 19197098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy.
    Takasaki S; Maeda K; Joh K; Yamakage S; Fukase S; Takahashi T; Suzuki M; Matsunaga A; Saito T
    Case Rep Nephrol Dial; 2015; 5(3):204-12. PubMed ID: 26955632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.